Abstract
The rate of esophageal adenocarcinoma is rising, and the lesion has a poor prognosis mainly because of late presentation. Barrett’s metaplasia is a major risk factor in the epidemiology of esophageal adenocarcinoma, as individuals with Barrett’s metaplasia have an increased risk of adenocarcinoma of the lower esophagus [1]. Although highly curable at its early stages, esophageal cancer is usually fatal when it is more advanced [2–4]. Treatment and subsequent outcome are linked to its histology, accurate staging, and the site of the tumor [5,6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stein HJ, Hoeft S, DeMeester TR (1993) Functional foregut abnormalities in Barrett’s esophagus. J Thorac Cardiovasc Surg 105:163–168
Steup WH, DeLeyn P, Deneffe I, et al (1996) Tumors of the esophagogastric junction: long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 5:S17–S26
Clark GW, Peters JH, Ireland AP, et al (1994) Nodal metastasis and sites of recurrence after en bloc esophagectomy of adenocarcinoma. Ann Thorac Surg 58:646–654
Hölscher AH, Bollschweiler E, Bumm R, et al (1995) Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma of the esophagus. Surgery 118:845–855
Lightdale CJ (1994) Staging of esophageal cancer. I. Endoscopic ultrasonography. Semin Oncol 21:438–446
Thompson WM, Halvorsen RA Jr (1994) Staging esophageal carcinoma II: CT and MRI. Semin Oncol 21:447–452
Macdonald CE, Wicks AC, Playford RJ (2000) Final results from 10 year cohort of patients undergoing surveillance for Barrett’s esophagitis: observational study. BMJ 321:1252–1255
Morales TG, Sampliner RE (1999) Barrett’s esophagus: an update on screening, surveillance and treatment. Arch Intern Med 159:1411–1416
Peters JH, Clark GW, Ireland AP, et al (1994) Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and non surveyed patients. J Thorac Cardiovasc Surg 108:813–821
Peters JH, Hoeft SF, Heimbucher J, et al (1994) Selection of patients for curative oe palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. Arch Surg 129:534–539
Cameron AJ, Lomboy CT, Pera M, et al (1992) Adenocarcinoma of esophagogastric junction and Barrett’s esophagus. Gastroenterology 103:1241–1245
Jankowski J, Harrison R, Perry I, et al (2000) Barrett’s metaplasia. Lancet 356:2079–2085
Hirota WK, Loughney TM, Lanzas DJ, Maydonovitch CL, Rholl V, Wong RKH (1999) Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116:277–285
Prach AT, Mohiuddin MA, Geisinger KR, et al (1997) Increasing incidence of Barrett’s esophagus: education, enthusiasm, or epidemiology [letter]? Lancet 350:933
Sanchez RC, Santalla PF, Retamero OMD (1995) Barrett esophagus: an epidemiological study in an area of Spain. Rev Esp Enferm Dig 87:353–355
Sarr MG, Hamilton SR, Marrone GC, et al (1985) Barrett’s esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg 149:187–193
Skinner DB, Walther BC, Riddell RH (1983) Barrett’s esophagus: comparison of benign and malignant cases. Ann Surg 198:554–566
Bonelli L (1993) Barrett’s esophagus: results of multicentric survey. G.O.S.P.E. (Gruppo Operativo per 10 studio delle Precancerosi Esofagee. Endoscopy 25:652–654
Yeh C, Hsu C, Ho A, et al (1997) Erosive esophagitis and Barrett’s esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci 42:702–706
Chen PH (1997) Review: Barrett’s esophagus in Taiwan. J. Gastroenterol Hepatol 12:S19–S22
Cameron AJ, Lomboy CT (1995) Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology 103:1241–1245
Hamilton SR, Smith RR, Camerone JL (1988) Prevalence and characteristic of Barrett’s esophagus in patients with adenocarcinoma of esophagus or esophagogastric junction. Hum Pathol 19:942–948
Blot WJ, Devesa SS, Kneller RW, et al (1993) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287–1289
Haggit RC (1992) Adenocarcinoma in Barrett’s esophagus: a new epidemic [editorial]? Hum Pathol 23:475–476
Pera M, Cameron AJ, Trastek VF, et al (1993) Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104:510–513
Jankowski J (2001) CRC cancer stats: Esophageal cancer. CRC Press, London
Poynton AR, Walsh TN, O’sullivan G, et al (1996) Carcinoma arising in familial barrett’s esophagus. Am J Gastroenterol 91:1855–1856
Fontolliet C, Ollyo JB, Brossard E (1994) Barrett’s esophagus may still progress. Gut 35(suppl):A27–A27
Monnier P, Fontolliet C, Savary M, et al (1987) Barrett’s esophagus or columnar epithelium of lower esophagus. Ballieres Clin Gastroenterol 14:769–789
Ollyo JB, Gonvers JJ, Froehlich F, et al (1990) Does Barrett’s esophagus regress after effective treatment of gastro-esophageal reflux? Schweiz Med Wochenschr 120:716–720
Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology (1998) Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 93:1028–1032
Cameron AJ (1998) Management of Barrett’s esophagus. Mayo Clin Proc 73:457–461
Barrett MT, Sanchez CA, Prevo LJ, et al (1999) Evolution in neoplastic cell lineage in Barrett’s esophagus. Nat Genet 22:106–109
Reid BJ, Blount PL, Rubin CE, et al (1992) Flow-cytometric and histological progression to malignancy in Barrett’s esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 102:1212–1219
Edwards MJ, Gable DR, Lentsch AB, et al (1996) The rationale for esophagectomy as the optimal therapy for Barrett’s esophagus with high-grade dysplasia. Ann Surg 223:585–589
Morisaki Y, Yoshizumi Y, Hiroyasu S, et al (1996) Adenoid cystis carcinoma of the esophagus: report of a case and review of the Japanese literature. Surg Today 26:1006–1009
Pera M, Trastek VF, Carpenter HA, et al (1992) Barrett’s esophagus with high grade dysplasia: an indication for esophagectomy: Ann Thorac Surg 54:199–204
Spechler SJ, Goyal RK (1986) Barrett’s esophagus. N Engl J Med 315:362–371
Spechler SJ, Robbins AH, Bloomfield Rubins H, et al (1984) Adenocarcinoma and Barrett’s esophagus: an overrated risk? Gastroenterology 87:927–933
Cameron AJ, Ott BJ, Payne WS (1985) The incidence in columnar-lined (Barrett’s) esophagus. N Engl J Med 313:857–859
Williamson WA, Ellis FH Jr, Gibbs SP, et al (1991) Barrett’s esophagus: prevalence and incidence of adenocarcinoma. Arch Intern Med 151:2212–2216
Drewitz DJ, Sampliner RE, Garewal HS (1997) The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92: 212–215
Shaheen NJ, Crosby MA, Bozymski EM, et al (2000) Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 119:333–338
Tuyns AJ (1992) Esophageal cancer in France and Switzerland: recent time trend. Eur J Cancer Prev 1:275–278
Day NE, Munoz N, Ghadirian P (1982) Epidemiology of esophageal cancer: a review. In: Correa P, Haenszel W (eds) Epidemiology of cancer of the digestive tract. Martinus Nijhoff, The Hague, pp 21–57
Brown LM, Swanson CA, Gridley G, et al (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J Nat! Cancer Inst 87:1104–1109
Chow W-H, Blot WJ, Vaughan TL, et al (1998) Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia. J Nat! Cancer Inst 90:150–155
Gray MR, Donnelly RJ, Kingsnorth IN, et al (1993) The role of smoking and alcohol in metaplasia and cancer risk in Barrett’s columnar lined esophagus. Gut 34:727–731
Spechler SJ, Sperber H, Doos WG, et al (1983) The prevalence of Barrett’s esophagus in patients with chronic peptic esophageal strictures. Dig Dis Sci 28:769–774
Weston AP, Badr AS, Topalovski M, et al (2000) Prospective evaluation of the prevalence of gastric Helicobacter pylori in patients with GERD, Barrett’s esophagus, Barrett’s dysplasia, and Barrett’s adenocarcinoma. Am J Gastroenterol 95:387–394
Chow W-H, Finkle WD, McLaughlin JK, et al (1995) The relation of gastresophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 274:474–477
Lagergren J, Bergstorm R, Lindgren A, et al (1999) Symptomatic gastresophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831
Patti MG, Goldberg HI, Arcerito M, et al (1996) Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and degree of mucosal injury. Am J Surg 94:2054–2059
Menke-Pluymers MBE, Hop WCJ, Dees J, et al (1993) Risk factors for the development of an adenocarcinoma in Barrett’s esophagus. Cancer 72:1155–1158
Jankowski J, Wright NA, Meltzer S, et al (1999) Molecular evolution of the metaplasia dysplasia sequence in the esophagus. Am J Pathol 154:969–974
Jankowski J (1993) Gene expression in Barrett’s mucosa: modulation of acute and chronic responses. Gut 34:1012–1014
Hamilton SR, Smith RR (1987) The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett’s esophagus. Am J Clin Pathol 87:301–312
Reid BJ, Weinstein WM, Lewin KJ, et al (1988) Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett’s esophagus with or without grossly recognizable neoplastic lesions. Gastroenterology 94:81–90
Garewal HS, Sampliner RE, Fennerty MB, et al (1991) Flow cytometry in Barrett’s esophagus: what have we learned so for? Dig Dis Sci 36:548–551
Boynton RF, Huang Y, Blount PL, et al (1991) Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancer. Cancer Res 51:5766–5769
Schneider PM, Casson AG, Levin B (1996) Mutation in p53 in Barrett’s esophagus and Barrett’s cancer: a prospective study of 98 cases. J Thorac Cardiovasc Surg 111:323–333
Sjogren RW, Johnson LF (1983) Barrett’s esophagus: a review. Am J Med 74:313–321
Bremner RM, DeMeester TR (1991) Surgical treatment of esophageal carcinoma. Gastroenterol Clin North Am 20:743–763
Starnes VA, Adkins RB, Ballinger JF, et al (1984) Barrett’s esophagus: a surgical entity. Arch Surg 119:563–567
Bytzer P, Christensen PB, Damkier P, Vinding K, Seersholm N (1999) Adenocarcinoma of the esophagus and Barrett’s esophagus: a population-based study. Am J Gastroenterol 94: 86–91
Sanfey H, Hamilton SR, Smith RRL (1985) Carcinoma arising in Barrett’s esophagus. Surg Gynecol Obstet 161:57–574
Akiyama H (1990) Surgery for cancer of the esophagus. Williams & Wilkins, Baltimore, p 10
Ojala K, Sorri M, Jokinin K (1982) Symptoms of carcinoma of the esophagus. Med J Aust 1:384–385
Cameron AJ, Zinmeiester AR, Ballard DJ, et al (1990) Prevalence of Columnar-lined (Barrett’s) esophagus. Gastroenterology 99:918–922
Bogomoletz WV, Molas G, Gayet B, et al (1989) Superficial squamous cell carcinoma of the esophagus: a report of 76 cases and review of the literature. Am J Surg Pathol 13:535–546
Goseki N, Koike M, Yoshida M (1992) Histopathologic characteristics of early stage esophageal carcinoma: a comparative study with gastric carcinoma. Cancer 69:1088–1093
Haruma K, Tokutomi T, Tsuda T, et al (1991) Superficial esophageal carcinoma: a report of 27 cases in Japan. Am J Gastroenterol 86:1723–1728
Zargar SA, Khuroo MS, Jan GM, et al (1991) Prospective comparison of the value of brushings before and after biopsy in the endoscopic diagnosis of gastroesophageal malignancy. Acta Cytol 35:549–552
Ohno S, Mori M, Tsutsui S, et al (1991) Growth patterns and prognosis of submucosal carcinoma of the esophagus: a pathologic study. Cancer 68:335–340
Thompson JJ, Zinsser KR, Enterline HT, et al (1983) Barrett’s metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 14:43–61
Richards FM, McKee SA, Rajpar MH, et al (1999) Germ-line E-cadherin gene (CDH1) mutations predispose to familial gastric and colorectal cancer. Hum Mol Genet 4:135–144
Canto MI, Setrakian S, Petras RE, et al (1996) Methylene blue selectively stains intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 44:1–7
Weston AP, Badr AS, Hassanein RS (1999) Prospective multivariate analysis of factors predictive of complete regression of Barrett’s esophagus. Am J Gastroenterol 94: 3420–3426
Stevens PD, Lightdale CJ, Green HR, et al (1994) Combined endoscopy with chemoendoscopy for the evaluation of Barrett’s esophagus. Gastrointest Endosc 40:747
Roth JA, Putnam JB, Rich TA, et al (1997) Cancer of the esophagus. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 980–1021
Akiyama H, Tsurumaru M, Kawamura T, et al (1981) Principles of surgical treatment for carcinoma of esophagus; analysis of lymph node involvement. Ann Surg 194: 438–446
Akiyama H, Tsurumaru M, Udagawa H, et al (1994) Radical dissection for cancer of the thoracic esophagus. Ann Surg 220:364–373
Falk GW, Catalano MF, Sivak MV Jr, et al (1994) Endosonography in the evolution of patients with Barrett’s esophagus and high grade dysplasia. Gastrointest Endosc 40:207–212
Ferguson MK, Naunheim KS (1997) Resection for Barrett’s mucosa with high-grade dysplasia and early adenocarcinoma: comparison of endoscopic biopsy and surgical pathology findings. J Thorac Cardiovasc Surg 114:824–829
Overholt BF, Panjehpou M, Haydek JM (1999) Photodynamic therapy for Barrett’s esophagus: followup in 100 cases. Gastrointest Endosc 49:1–7
Streitz JM, Andrews CW, Ellis FH Jr (1993) Endoscopic surveillance of Barrett’s esophagus: does it help? J Thorac Cardiovasc Surg 105:383–387
Levine DS, Haggit RC, Blount PL, et al (1993) An endoscopy biopsy protocol can differentiate high grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 105:40–50
Hagen JA, Peters JH, Demeester TR, et al (1993) Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 106:850–859
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Japan
About this paper
Cite this paper
Ishaq, S., Harrison, R.F., Jankowski, J.A. (2002). Superficial Esophageal Cancer: Adenocarcinoma Related to Barrett’s Metaplasia and Adenoid Cystic Carcinoma. In: Imamura, M. (eds) Superficial Esophageal Neoplasm. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67873-1_22
Download citation
DOI: https://doi.org/10.1007/978-4-431-67873-1_22
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67997-4
Online ISBN: 978-4-431-67873-1
eBook Packages: Springer Book Archive